Selected research
Industry Research
Cat Vaccines Industry Research Report 2026
Market perspective
The global Cat Vaccines market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Cat Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Cat Vaccines is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Cat Vaccines is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Cat Vaccines include Zoetis (Pfizer), Eli Lilly, Bayer Healthcare, Virbac, Vetoquinol S.A, Merial (Sanofi), Merck Animal Health, Heska Co. and Ceva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Cat Vaccines market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cat Vaccines Market by Company
Zoetis (Pfizer)
Eli Lilly
Bayer Healthcare
Virbac
Vetoquinol S.A
Merial (Sanofi)
Merck Animal Health
Heska Co.
Ceva
Boehringer Ingelheim
Cat Vaccines Segment by Type
DNA Vaccines
Conjugate Vaccines
Attenuated Live Vaccines
Toxoid Vaccines
Inactivated Vaccines
Subunit Vaccines
Recombinant Vaccines
Cat Vaccines Segment by Application
Below 6 Months
Above 6 Months
Cat Vaccines Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cat Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cat Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cat Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Cat Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Cat Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Cat Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- DNA Vaccines
- Conjugate Vaccines
- Attenuated Live Vaccines
- Toxoid Vaccines
- Inactivated Vaccines
- Subunit Vaccines
- Recombinant Vaccines
Applications
- Below 6 Months
- Above 6 Months
Companies covered
- Zoetis (Pfizer)
- Eli Lilly
- Bayer Healthcare
- Virbac
- Vetoquinol S.A
- Merial (Sanofi)
- Merck Animal Health
- Heska Co.
- Ceva
- Boehringer Ingelheim
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Cat Vaccines Market Size (2021-2032)
- 2.2.2 Global Cat Vaccines Sales (2021-2032)
- 2.2.3 Global Cat Vaccines Market Average Price (2021-2032)
- 2.3 Cat Vaccines by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 DNA Vaccines
- 2.3.3 Conjugate Vaccines
- 2.3.4 Attenuated Live Vaccines
- 2.3.5 Toxoid Vaccines
- 2.3.6 Inactivated Vaccines
- 2.3.7 Subunit Vaccines
- 2.3.8 Recombinant Vaccines
- 2.4 Cat Vaccines by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Below 6 Months
- 2.4.3 Above 6 Months
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Cat Vaccines Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Cat Vaccines Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Cat Vaccines Revenue of Manufacturers (2021-2026)
- 3.4 Global Cat Vaccines Average Price by Manufacturers (2021-2026)
- 3.5 Global Cat Vaccines Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Cat Vaccines, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Cat Vaccines, Product Type & Application
- 3.8 Global Manufacturers of Cat Vaccines, Established Date
- 3.9 Global Cat Vaccines Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Zoetis (Pfizer)
- 4.1.1 Zoetis (Pfizer) Company Information
- 4.1.2 Zoetis (Pfizer) Business Overview
- 4.1.3 Zoetis (Pfizer) Cat Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Zoetis (Pfizer) Cat Vaccines Product Portfolio
- 4.1.5 Zoetis (Pfizer) Recent Developments
- 4.2 Eli Lilly
- 4.2.1 Eli Lilly Company Information
- 4.2.2 Eli Lilly Business Overview
- 4.2.3 Eli Lilly Cat Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Eli Lilly Cat Vaccines Product Portfolio
- 4.2.5 Eli Lilly Recent Developments
- 4.3 Bayer Healthcare
- 4.3.1 Bayer Healthcare Company Information
- 4.3.2 Bayer Healthcare Business Overview
- 4.3.3 Bayer Healthcare Cat Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Bayer Healthcare Cat Vaccines Product Portfolio
- 4.3.5 Bayer Healthcare Recent Developments
- 4.4 Virbac
- 4.4.1 Virbac Company Information
- 4.4.2 Virbac Business Overview
- 4.4.3 Virbac Cat Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Virbac Cat Vaccines Product Portfolio
- 4.4.5 Virbac Recent Developments
- 4.5 Vetoquinol S.A
- 4.5.1 Vetoquinol S.A Company Information
- 4.5.2 Vetoquinol S.A Business Overview
- 4.5.3 Vetoquinol S.A Cat Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Vetoquinol S.A Cat Vaccines Product Portfolio
- 4.5.5 Vetoquinol S.A Recent Developments
- 4.6 Merial (Sanofi)
- 4.6.1 Merial (Sanofi) Company Information
- 4.6.2 Merial (Sanofi) Business Overview
- 4.6.3 Merial (Sanofi) Cat Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Merial (Sanofi) Cat Vaccines Product Portfolio
- 4.6.5 Merial (Sanofi) Recent Developments
- 4.7 Merck Animal Health
- 4.7.1 Merck Animal Health Company Information
- 4.7.2 Merck Animal Health Business Overview
- 4.7.3 Merck Animal Health Cat Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Merck Animal Health Cat Vaccines Product Portfolio
- 4.7.5 Merck Animal Health Recent Developments
- 4.8 Heska Co.
- 4.8.1 Heska Co. Company Information
- 4.8.2 Heska Co. Business Overview
- 4.8.3 Heska Co. Cat Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Heska Co. Cat Vaccines Product Portfolio
- 4.8.5 Heska Co. Recent Developments
- 4.9 Ceva
- 4.9.1 Ceva Company Information
- 4.9.2 Ceva Business Overview
- 4.9.3 Ceva Cat Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Ceva Cat Vaccines Product Portfolio
- 4.9.5 Ceva Recent Developments
- 4.10 Boehringer Ingelheim
- 4.10.1 Boehringer Ingelheim Company Information
- 4.10.2 Boehringer Ingelheim Business Overview
- 4.10.3 Boehringer Ingelheim Cat Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Boehringer Ingelheim Cat Vaccines Product Portfolio
- 4.10.5 Boehringer Ingelheim Recent Developments
5 Global Cat Vaccines Market Scenario by Region
- 5.1 Global Cat Vaccines Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Cat Vaccines Sales by Region: 2021-2032
- 5.2.1 Global Cat Vaccines Sales by Region: 2021-2026
- 5.2.2 Global Cat Vaccines Sales by Region: 2027-2032
- 5.3 Global Cat Vaccines Revenue by Region: 2021-2032
- 5.3.1 Global Cat Vaccines Revenue by Region: 2021-2026
- 5.3.2 Global Cat Vaccines Revenue by Region: 2027-2032
- 5.4 North America Cat Vaccines Market Facts & Figures by Country
- 5.4.1 North America Cat Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Cat Vaccines Sales by Country (2021-2032)
- 5.4.3 North America Cat Vaccines Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Cat Vaccines Market Facts & Figures by Country
- 5.5.1 Europe Cat Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Cat Vaccines Sales by Country (2021-2032)
- 5.5.3 Europe Cat Vaccines Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Cat Vaccines Market Facts & Figures by Country
- 5.6.1 Asia Pacific Cat Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Cat Vaccines Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Cat Vaccines Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Cat Vaccines Market Facts & Figures by Country
- 5.7.1 South America Cat Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Cat Vaccines Sales by Country (2021-2032)
- 5.7.3 South America Cat Vaccines Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Cat Vaccines Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Cat Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Cat Vaccines Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Cat Vaccines Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Cat Vaccines Sales by Type (2021-2032)
- 6.1.1 Global Cat Vaccines Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Cat Vaccines Sales Market Share by Type (2021-2032)
- 6.2 Global Cat Vaccines Revenue by Type (2021-2032)
- 6.2.1 Global Cat Vaccines Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Cat Vaccines Revenue Market Share by Type (2021-2032)
- 6.3 Global Cat Vaccines Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Cat Vaccines Sales by Application (2021-2032)
- 7.1.1 Global Cat Vaccines Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Cat Vaccines Sales Market Share by Application (2021-2032)
- 7.2 Global Cat Vaccines Revenue by Application (2021-2032)
- 7.2.1 Global Cat Vaccines Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Cat Vaccines Revenue Market Share by Application (2021-2032)
- 7.3 Global Cat Vaccines Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Cat Vaccines Value Chain Analysis
- 8.1.1 Cat Vaccines Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Cat Vaccines Production Mode & Process
- 8.2 Cat Vaccines Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Cat Vaccines Distributors
- 8.2.3 Cat Vaccines Customers
9 Global Cat Vaccines Analyzing Market Dynamics
- 9.1 Cat Vaccines Industry Trends
- 9.2 Cat Vaccines Industry Drivers
- 9.3 Cat Vaccines Industry Opportunities and Challenges
- 9.4 Cat Vaccines Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst